XML 59 R42.htm IDEA: XBRL DOCUMENT v3.22.2
STOCK-BASED COMPENSATION (Tables)
 12 Months Ended
May 29, 2022
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Recognized Stock-Based Compensation Expense
Stock-based compensation expense included in continuing operations was as follows:  
Fiscal Year Ended
(in millions)May 29, 2022May 30, 2021May 31, 2020
Stock options$6.6 $8.6 $6.1 
Restricted stock units7.5 9.5 8.0 
Darden stock units26.9 32.6 19.6 
Equity-settled performance-based restricted stock units15.3 17.9 16.1 
Employee stock purchase plan2.7 2.5 1.8 
Director compensation program/other1.5 1.3 1.4 
Total$60.5 $72.4 $53.0 
Excess income tax benefits related to the exercise of stock options and vesting of other equity-settled stock-based compensation recognized in income tax expense from continuing operations was as follows:  
Fiscal Year Ended
(in millions)May 29, 2022May 30, 2021May 31, 2020
Income tax benefits$11.9 $14.0 $10.0 
Weighted-Average Fair Value and Related Assumptions for Stock-Based Compensation
The weighted-average fair value of non-qualified stock options and the related assumptions used in the Black-Scholes model to record stock-based compensation are as follows:
  
Granted in Fiscal Year Ended
May 29, 2022May 30, 2021May 31, 2020
Weighted-average fair value$41.02 $20.07 $19.94 
Dividend yield3.2 %3.0 %3.0 %
Expected volatility of stock39.6 %37.3 %22.5 %
Risk-free interest rate0.9 %0.4 %1.9 %
Expected option life (in years)6.36.46.3
Weighted-average exercise price per share$148.20 $78.84 $124.24 
The weighted-average grant date fair value of equity-settled PRSUs and the related assumptions used in the Monte Carlo simulation to record stock-based compensation are as follows:
  
Granted in Fiscal Year Ended
May 29, 2022May 30, 2021May 31, 2020
Dividend yield (1)0.0 %0.0 %0.0 %
Expected volatility of stock53.4 %50.5 %23.1 %
Risk-free interest rate0.4 %0.1 %1.8 %
Expected option life (in years)2.82.82.9
Weighted-average grant date fair value per unit$172.34 $83.46 $98.16 
(1)Assumes a reinvestment of dividends.
Summary Of Stock Option Activity
The following table presents a summary of our stock option activity as of and for the year ended May 29, 2022:
  Options
(in millions)		Weighted-Average
Exercise Price
Per Share		Weighted-Average
Remaining
Contractual Life (Yrs)		Aggregate
Intrinsic Value
(in millions)
Outstanding beginning of period2.15$79.896.02$136.4
Options granted0.15148.20
Options exercised(0.48)62.33
Options canceled(0.01)113.08
Outstanding end of period1.81$89.975.75$68.8
Exercisable1.02$74.044.22$52.9
Summary Of Restricted Stock and RSU Activity
The following table presents a summary of our RSU activity as of and for the fiscal year ended May 29, 2022:
  Shares
(in millions)		Weighted-Average
Grant Date Fair
Value Per Share
Outstanding beginning of period0.26$96.90
Shares granted0.06146.16
Shares vested(0.07)105.79
Shares canceled—106.94
Outstanding end of period0.25$107.00
Summary Of Darden Stock Unit Activity
The following table presents a summary of our Darden stock unit activity as of and for the fiscal year ended May 29, 2022:
(All units settled in cash)Units
(in millions)		Weighted-Average
Fair Value
Per Unit
Outstanding beginning of period0.80$143.23
Units granted0.33146.56
Units vested(0.23)145.96
Units canceled(0.08)113.74
Outstanding end of period0.82$126.04
Summary Of Performance Stock Unit Activity The following table presents a summary of our equity-settled PRSU activity as of and for the fiscal year ended May 29, 2022:
Units
(in millions)		Weighted-Average
Grant Date
Fair Value
Per Unit
Outstanding beginning of period0.48$100.38
Units granted0.08172.34
Units granted performance impact0.01112.87
Units vested(0.15)102.45
Units canceled(0.01)122.26
Outstanding end of period0.41$114.10